Welcome to our dedicated page for Globe Life SEC filings (Ticker: GL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Globe Life Inc. filings document operating results, governance and capital-structure disclosures for an insurance holding company focused on life and supplemental health insurance. Current reports include earnings releases furnished on Form 8-K, with disclosures on net income, net operating income, underwriting margins, premium revenue and guidance.
Proxy and governance filings cover director elections, shareholder voting results, advisory executive compensation matters, board composition, non-employee director compensation and executive retirement plan amendments. The filing record also identifies registered securities including common stock and subordinated debt, alongside recurring disclosures tied to shareholder meetings and corporate governance procedures.
Globe Life Inc. has a planned Rule 144 sale of 30,000 common shares. The shares are to be sold through Apex Clearing on the NYSE, with an approximate sale date of 02/06/2026 and an aggregate market value of $4,408,500.
The 30,000 shares were acquired on 02/06/2026 via a stock option exercise from Globe Life Inc., with payment described as proceeds of the stock option exercise. The filing also notes 78,637,130 shares outstanding for context.
Globe Life Inc. filed a Form 13F reporting institutional holdings: the report lists 2 information-table entries with a total market value of $397,845,466. The report was signed by Christopher T. Moore on 02-06-2026.
Globe Life Inc. filed a current report to note that it issued a press release announcing its fourth quarter 2025 financial results. The press release is attached as Exhibit 99.1 and incorporated by reference.
The company specifies that this earnings information, including Exhibit 99.1, is being furnished under Item 2.02 and is not deemed “filed” under the Exchange Act, which affects how it may be used in certain legal contexts.
The Vanguard Group filed an amended Schedule 13G reporting a passive ownership stake in Globe Life Inc. common stock. It reports beneficial ownership of 10,090,653 shares, representing 12.67% of the outstanding common stock as of the event date.
The Vanguard Group has shared voting power over 704,888 shares and shared dispositive power over 10,090,653 shares, with no sole voting or dispositive power. The filing states the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of Globe Life. Vanguard’s clients have the right to receive dividends and sale proceeds, and no other individual client holds more than 5% of the class. The filing also notes an internal realignment effective January 12, 2026, after which certain Vanguard subsidiaries are expected to report beneficial ownership separately.
Globe Life Inc. director Matthew J. Adams filed an amended insider report after acquiring additional company stock. On January 2, 2026, he acquired 1,373 shares of Globe Life common stock at a reported price of $0 per share, increasing his direct holdings.
Following this transaction, Adams now beneficially owns 2,558.3971 Globe Life shares directly and holds no shares indirectly. The amendment clarifies that this total was corrected to include 2.3971 shares previously acquired through the company’s dividend reinvestment plan, while noting that the original filing was submitted on time.
Globe Life Inc. (GL) director reports stock acquisition
A Globe Life Inc. director, Marilyn A. Alexander, reported acquiring 458 shares of the company’s common stock on 01/02/2026 at a stated price of $0 per share. After this transaction, she beneficially owns 22,606.7364 shares of Globe Life common stock in direct ownership.
The footnote explains that this total includes 102.7315 dividend right restricted stock units that were acquired on restricted stock units since the date of the last report. No derivative securities transactions were reported in this filing.
Globe Life Inc. (GL) director reports stock acquisition
A director of Globe Life Inc., Linda L. Addison, reported acquiring 723 shares of Globe Life common stock on 01/02/2026 in a transaction coded "A" at a price of $0 per share. Following this transaction, she beneficially owns 20,406.1005 shares of Globe Life common stock in direct form. The filing notes that this total includes 140.5747 dividend right restricted stock units that were acquired in connection with restricted stock units since the date of the last report.
Globe Life Inc. director reports acquisition of company stock
A Globe Life Inc. director reported acquiring 1,373 shares of the company’s common stock on 01/02/2026 at a stated price of $0 per share. Following this transaction, the director beneficially owns 10,835.951 shares directly and no shares indirectly. The filing notes that this total includes 52.429 shares acquired through the company’s dividend reinvestment plan since the date of the last report.
Globe Life Inc. director reports stock acquisition
A director of Globe Life Inc. reported acquiring 1,373 shares of the company’s common stock on 01/02/2026 at a reported price of $0 per share. After this transaction, the director beneficially owns 18,747.3763 shares directly. The filing notes that this total includes 108.1129 shares accumulated through the company’s dividend reinvestment plan since the prior report.
Globe Life Inc. director Alice S. Cho reported acquiring company stock in an insider transaction. On 01/02/2026, she acquired 1,373 shares of Globe Life common stock at a reported price of $0, indicating an equity award rather than an open-market purchase. Following this transaction, she beneficially owned 5,877.0607 shares of Globe Life common stock in direct ownership.
The footnote explains that this total includes 37.1003 dividend right restricted stock units that were acquired in connection with restricted stock units since the date of the last report, showing that part of the position is tied to equity-based compensation that accrues dividend equivalents.